Saturday, April 11, 2026

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

G7 Diplomacy: South Korea’s Foreign Minister Discusses Hormuz Strait Tensions with U.S. Officials

South Korean Foreign Minister Cho Hyun and U.S. Under Secretary Allison Hooker discussed Middle Eastern tensions and investment agreements.

NVIDIA Shares Climb 1.69% After 9% Drop, Driven by Investor Buy-Backs

NVIDIA shares rebounded by 1.69% after a sharp decline, driven by investors buying at a discount amid concerns over export controls.

Tag: Penetrium Bioscience

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Top News

- Our Sponsors Ad -

Follow us